Prime Highlights: Bristol Myers Squibb has introduced Kopozgo, India’s first approved cardiac myosin inhibitor, offering a new treatment option for obstructive hypertrophic cardiomyopathy (oHCM). The launch addresses a major unmet…
Prime Highlights Ophthalmologists in Bengaluru are seeing a sharp rise in myopia and dry eye syndrome among children, primarily due to excessive screen time and reduced outdoor activity post-pandemic. Experts…
Prime Highlights: India could be at the highest long-term risk for chikungunya, with over 5 million people at risk annually due to local conditions rather than climate. The study highlights…
Prime Highlight Around 41,000 children in Karnataka suffer from congenital heart disease (CHD), underscoring the urgent need for improved diagnosis and treatment systems. The state plans to integrate pregnancy ultrasounds…
Prime Highlight India’s healthcare sector is set to touch $650 billion by 2025, with AI expected to add $30 billion to the GDP. AI adoption is transforming healthcare delivery with…
Prime Highlights Delhi-NCR is witnessing a sharp spike in flu and viral infections, with H3N2 Influenza A identified as the main virus. Doctors warn that illnesses are lasting up to…
Prime Highlights: MGM Hospital in Warangal and RIMS in Adilabad will now offer organ transplantation services, expanding access beyond Hyderabad. Health Minister Damodar Rajanarasimha has called for organ retrieval centres…
Prime Highlight Tamil Nadu sees a sharp rise in seasonal viral fevers, with Influenza A (H1N1, H3N2), RSV, and rhinovirus being the main drivers. Fever cases, which once peaked in…
Prime Highlights IIT Guwahati researchers have developed a nanosensor that can detect mercury and harmful antibiotics in water within less than 10 seconds. The innovation highlights nanotechnology’s potential to fight…
Prime Highlights CSIR-CCMB researchers in Hyderabad have discovered a mechanism called Programmed Cell Revival (PCR), showing that cells on the verge of death can revive and restore normal functioning. The…